Full Press Release Details
argenx Announces Annual General Meeting of Shareholders on May 2, 2023.
ARGX
argenx Announces Annual General Meeting of Shareholders on May 2, 2023
Key Takeaway: argenx Announces Annual General Meeting of Shareholders on May 2, 2023
Price reaction · baseline $358.47 (2023-03-16 close) · hit after-hours · clean, no other ARGX news in the window
day 0 close · peak
+0.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis